Assignee
CYTOIMMUNE THERAPEUTICS INC
US·2 granted patents·7 pending applications·3 citations·filing 2016–2024
Top patents by PatentIndex Score
9 records- 0177US11045543B2EGFR-directed car therapy for glioblastomaCYTOIMMUNE THERAPEUTICS INC·Filed 2016·Granted Jun 29, 2021·2 cites·33 claims
- 0277US10961312B2FLT3 directed car cells for immunotherapyCYTOIMMUNE THERAPEUTICS INC·Filed 2017·Granted Mar 30, 2021·1 cites·18 claims
- 0373US2025179194A1Compositions and methods for immunotherapy targeting flt3, pd-1, and/or pd-l1CYTOIMMUNE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0459US2021308261A1Egfr-directed car therapy for glioblastomaCYTOIMMUNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0559US2021301024A1Compositions and methods for immunotherapy targeting flt3, pd-1, and/or pd-l1CYTOIMMUNE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0659US2021269534A1Flt3 directed car cells for immunotherapyCYTOIMMUNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0755US2023331872A1Bispecific antibody car cell immunotherapyCYTOIMMUNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0855US2022281982A1Bispecific antibody car cell immunotherapyCYTOIMMUNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0947US2021087275A1Bispecific antibody car cell immunotherapyCYTOIMMUNE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →